LAMA84-r/iRFP stable cell line

LAMA84-r/iRFP cells are derived from the human chronic myeloid leukemia cell line LAMA84-r by stably integration of a constitutive miRFP670 stably expression construct. The LAMA84-r cell line is resistant to the tyrosine kinase inhibitor imatinib mesylate, and is paired to the LAMA84-s cell line which is sensitive to imatinib. The paired LAMA84-r and LAMA84-s cell lines are useful models of sensitivity and resistance to a tyrosine kinase inhibitor used in the treatment of chronic myeloid leukemia. LAMA84-r/iRFP cells stably express miRFP670, can be used for in vitro assays and in vivo imaging.